Basit öğe kaydını göster

dc.contributor.authorChen, Mindy
dc.contributor.authorHatemi, Gulen
dc.contributor.authorParis, Maria
dc.contributor.authorYazici, Yusuf
dc.contributor.authorMelikoglu, Melike
dc.contributor.authorMahr, Alfred
dc.contributor.authorTakeno, Mitsuhiro
dc.contributor.authorKim, Do-Young
dc.contributor.authorCheng, Sue
dc.contributor.authorMcCue, Shannon
dc.date.accessioned2021-03-03T08:47:12Z
dc.date.available2021-03-03T08:47:12Z
dc.identifier.citationHatemi G., Mahr A., Takeno M., Kim D., Melikoglu M., Cheng S., McCue S., Paris M., Chen M., Yazici Y., "Improvements and correlations in oral ulcers, disease activity, and quality of life in Behcet syndrome patients treated with apremilast: A phase III randomized, double-blind, placebo-controlled study (RELIEF)", Annual Meeting of the American-Academy-of-Dermatology (AAD), Washington, Kiribati, 1 - 05 Mart 2019, cilt.81
dc.identifier.othervv_1032021
dc.identifier.otherav_197c3166-e7a5-41ee-a580-160353176f95
dc.identifier.urihttp://hdl.handle.net/20.500.12627/22408
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectDermatoloji
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectKlinik Tıp
dc.subjectDERMATOLOJİ
dc.titleImprovements and correlations in oral ulcers, disease activity, and quality of life in Behcet syndrome patients treated with apremilast: A phase III randomized, double-blind, placebo-controlled study (RELIEF)
dc.typeBildiri
dc.contributor.departmentAssistance Publique Hopitaux Paris (APHP) , ,
dc.identifier.volume81
dc.contributor.firstauthorID157470


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster